Skin cancer is often highly treatable when caught early, but when a diagnosis is missed or delayed, this otherwise relatively treatable form of cancer can cause real damage, potentially including death.
A failure to recognize or act on warning signs can allow cancer to progress from a localized, manageable condition into an advanced disease that spreads to other parts of the body. When this happens, patients and families are often left asking how an opportunity for early intervention was lost.
Why failures to diagnose occur, and what can be done in their aftermath
Missed skin cancer diagnoses can occur for many reasons, even within the four walls of a single clinic. A suspicious lesion may be dismissed as benign, misidentified as a rash or infection or inadequately biopsied. In some cases, a biopsy is performed but the results are misread or not communicated promptly. Other times, follow-up is delayed or never scheduled, even when pathology reports indicate abnormal or inconclusive findings. Each of these failures can allow cancer cells time to grow and spread.
When skin cancer metastasizes, treatment becomes far more aggressive and uncertain. Melanoma, in particular, is known for its ability to spread rapidly to lymph nodes, organs and the brain. Basal cell and squamous cell carcinomas, while often less aggressive, can also cause serious harm if left untreated. Advanced disease may require extensive surgery, chemotherapy, immunotherapy or radiation, all of which carry significant risks and side effects.
The human cost of a missed diagnosis can be profound. Patients may endure invasive treatments, prolonged hospitalizations and a drastically altered quality of life as a result of such errors. Prognosis often worsens, and survival rates can drop sharply once cancer spreads. As a result, some missed diagnoses – particularly those that a medical professional should have caught if they had been exercising a reasonable standard of care – are legally actionable.
With that said, not every poor outcome constitutes actionable medical malpractice. Medical malpractice involves a failure to meet an accepted standard of care within a particular specialty and under certain circumstances. In skin cancer cases, this may include failing to perform a biopsy when warranted, misinterpreting test results, ignoring patient complaints or delaying referral to a specialist. A key question is whether a reasonably careful provider would have acted differently under similar circumstances and whether earlier diagnosis would likely have changed the outcome.
Oftentimes, when skin cancer spreads after a missed diagnosis, patients deserve answers and accountability. While legal action cannot undo a missed diagnosis, it can potentially help affected patients to secure the justice that they deserve.